GHRP-2 10mg. Used to support growth hormone release, muscle growth, recovery, and body composition. Lab tested, discreetly shipped across Canada.
FormatLyophilized Vial
ConcentrationDependent on reconstitution with BAC water
Pack Size Selected: 5 Pack
Pay with Interac e-Transfer or Crypto
HPLC verified. COA on file for this batch
Ships from within Canada; No Customs
Discreet plain packaging; always
24h dispatch; Tracked Delivery
GHRP-2 (Growth Hormone Releasing Peptide 2) is a synthetic hexapeptide and potent agonist of the growth hormone secretagogue receptor (GHS-R1a). A ghrelin receptor that mediates endogenous growth hormone pulse stimulation from the pituitary gland. iLab Pharma’s formulation supplies 10mg as a lyophilized vial, preserving peptide structural integrity and potency across storage conditions until reconstitution; standard practice for GHRPs where aqueous stability at ambient temperature is limited and lyophilized storage maintains compound activity across extended research timelines.
GHRP-2’s mechanism of action operates through GHS-R1a receptor binding in the hypothalamus and pituitary, stimulating growth hormone secretion through two complementary pathways, directly stimulating pituitary somatotroph cells to release GH, and simultaneously suppressing somatostatin tone at the hypothalamic level, reducing the inhibitory signal that limits GH pulse amplitude. This dual mechanism produces a more robust GH secretory response than direct pituitary stimulation alone, and distinguishes GHRP-2 from GHRH analogues like Tesamorelin and CJC-1295 which operate exclusively through GHRH receptor stimulation. The combination of GHRP-2 with a GHRH analogue produces synergistic GH secretion that exceeds either compound administered alone. Its a well documented research interaction that makes GHRP-2 one of the most frequently studied compounds in GH secretagogue combination research.
GHRP-2 is one of the most potent GHRPs in the research literature, with documented GH stimulation activity superior to GHRP-6 at equivalent doses attributed to GHRP-2’s stronger GHS-R1a binding affinity and reduced appetite stimulating activity compared to its predecessor. This potency and receptor affinity profile makes GHRP-2 a frequently selected reference compound in comparative GHRP research examining dose response relationships across the GHS-R1a agonist peptide family. CSD stocks GHRP-2 alongside Tesamorelin in the growth hormone secretagogue range, giving researchers access to both GHS-R1a agonist and GHRH receptor agonist mechanisms from a single verified Canadian supplier for complete GH axis stimulation research coverage.
iLab Pharma formulations are stocked by Canada Steroid Depot following the same rigorous third party lab verification process applied to every product in our range. Each batch is tested for concentration accuracy and purity before being made available, with COA documentation available on request. CSD’s sourcing standards apply uniformly across all manufacturers we carry, and iLab Pharma’s GHRP-2 meets those standards consistently. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior.
Reconstitute with bacteriostatic water prior to use. Store lyophilized peptide at 2–8°C away from direct light. Once reconstituted refrigerate and use within 28 days. Intended for research purposes only.
Commonly researched alongside CJC-1295 and Ipamorelin in comparative GH secretagogue combination and GHS-R1a agonist studies. Browse CSD’s full peptide range for complete sourcing.
GHRP-2, or Growth Hormone Releasing Peptide 2, is a synthetic hexapeptide growth hormone secretagogue also known as pralmorelin. It acts as an agonist at the growth hormone secretagogue receptor, the same receptor activated by the endogenous hormone ghrelin. GHRP-2 has been extensively studied for its ability to stimulate pituitary growth hormone release and investigate the regulation of the GH/IGF-1 axis. This product contains 10mg of lyophilized GHRP-2 in a single vial for laboratory research.
GHRP-2 is primarily researched for growth hormone secretion, pituitary function, ghrelin receptor signaling, and regulation of the GH/IGF-1 axis. Human studies have also examined its effects on appetite, food intake, endocrine responses, and the diagnostic assessment of growth hormone secretion. Its strong GH releasing activity has made it one of the most extensively studied members of the growth hormone releasing peptide family.
GHRP-2 activates the growth hormone secretagogue receptor, also known as GHSR-1a or the ghrelin receptor. Activation of this receptor stimulates signaling within the hypothalamic pituitary system and promotes release of endogenous growth hormone from pituitary somatotroph cells. This pathway is distinct from the GHRH receptor pathway, although growth hormone secretagogues and GHRH can produce complementary effects on GH secretion.
GHRP-2, GHRP-6, and Ipamorelin are all growth hormone secretagogues that act through the ghrelin receptor, but they have different pharmacological profiles. GHRP-2 is a potent stimulator of growth hormone release and has also been associated with appetite and additional pituitary hormone responses. GHRP-6 is likewise associated with strong ghrelin like appetite signaling, while Ipamorelin was developed as a more selective growth hormone secretagogue with less activity involving ACTH and cortisol in experimental studies.
Yes! This batch is HPLC tested to verify GHRP-2 identity and content accuracy at 10mg per vial. A certificate of analysis is available.
